Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

16 results
Display

Recommendations for gynecologic cancer care during the COVID-19 pandemic

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gynecologic oncology at the time of COVID-19 outbreak

Bogani G, Brusadelli C, Guerrisi R, Lopez S, Signorelli M, Ditto A, Raspagliesi F

The World Health Organization (WHO) classified the novel coronavirus (i.e., coronavirus disease 2019 [COVID-19]) as a global public health emergency. COVID-19 threatens to curtail patient access to evidence-based treatment. Medicine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
FIGO staging in ovarian carcinoma and histological subtypes

Kehoe S

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists

Wang Y, Zhang S, Wei L, Lin Z, Wang X, Wang J, Hua K, Cui M, Wang J, Wang S, Di W, Wang Y, An R, Xi M, Guo R, Zhou Q, Xie X, Xue F

The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014

Yue X, Pruemer JM, Hincapie AL, Almalki ZS, Guo JJ

Objective: This study estimated nationally representative medical expenditures of gynecologic cancers, described treatment patterns and assessed key risk factors associated with the economic burden in the United States. Methods: A retrospective...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells

Yue Y, Xia L, Xu S, Wang C, Wang X, Lu W, Xie X

Objective: As cancer stem cells (CSCs) are considered as the origin of tumor development, recurrence, and drug resistance, we aimed to explore the mechanism related to modulating stemness in CSCs,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epithelial ovarian cancer: a review of preoperative imaging features indicating suboptimal surgery

Jeong SY, Kim TJ, Park BK

Epithelial ovarian cancer has been traditionally treated with cytoreductive surgery and chemotherapy. Optimal surgery is the key to improving the prognosis, and, thus, preoperative imaging should be carefully assessed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparing efficacy of high-dose rate brachytherapy versus helical tomotherapy in the treatment of cervical cancer

Kim S, Lee S, Hong JH, Park YJ, Song JY, Lee JK, Lee NW

Objective: Boost radiation using brachytherapy (BT) is a standard treatment for local disease control in concomitant chemoradiation therapy (CCRT) for advanced cervical cancer. However, it is associated with gastrointestinal and genitourinary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Stage III uterine serous carcinoma: modern trends in multimodality treatment

Li JY, Young MR, Huang G, Litkouhi B, Santin A, Schwartz PE, Damast S

Objective: To examine outcomes in a modern treatment era for stage III uterine serous carcinoma (USC). Methods: Fifty women were retrospectively identified as 2009 International Federation of Gynecology and Obstetrics stage...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study

Kim MK, Seong SJ, Park DC, Hong JH, Roh JW, Kang SB

Objective: To compare the diagnostic accuracy of dilatation and curettage (D&C) versus endometrial aspiration biopsy in follow-up evaluation of patients treated with progestin for endometrial hyperplasia (EH) Methods: A prospective...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy

Wu X, Qin J, Shen T, Fei W, Chen L, Xie X, Lu W

Objective: To assess the outcomes and toxic effects of 5-day actinomycin D (Act-D) salvage therapy and to explore the predictors of Act-D resistance in patients with low-risk gestational trophoblastic neoplasia...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma

Xiang M, Kidd EA

Objective: To better delineate optimal management of high-risk, early-stage endometrial cancer, as national guidelines permit substantial practice variations. Methods: Patients with International Federation of Gynecology and Obstetrics (FIGO) stage IB grade...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma

Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Mikami M, Enomoto T, Katabuchi H, Aoki D

Objective: International Federation of Gynecology and Obstetrics (FIGO) staging for ovarian, fallopian tube, and peritoneal cancers was revised in 2014. The aim of this study is to clarify whether the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database

Shin W, Won YJ, Yoo CW, Lim J, Lim MC

Objective: Primary peritoneal cancer (PPC), ovarian cancer (OC), and fallopian tube cancer (FTC) are considered as a single disease group. As knowledge of the pathogenesis and clinical presentation of peritoneal,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety evaluation of abdominal trachelectomy in patients with cervical tumors ≥2 cm: a single-institution, retrospective analysis

Okugawa K, Yahata H, Sonoda K, Ohgami T, Yasunaga M, Kaneki E, Kato K

Objective: For oncologic safety, vaginal radical trachelectomy is generally performed only in patients with cervical cancers smaller than 2 cm. However, because inclusion criteria for abdominal trachelectomy are controversial, we...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma

Kajiyama H, Suzuki S, Yoshikawa N, Tamauchi S, Shibata K, Kikkawa F

Objective: The impact of systematic retroperitoneal lymphadenectomy (SRL) remains controversial in patients with advanced ovarian clear-cell carcinoma (CCC) who are optimally debulked. Methods: Between 1986 and 2017, a total of 3,227...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr